Share

Search your stocks

Ctrl+K

HPC Biosciences Ltd.HPC Biosciences Ltd.

25.68(+0.00%)

1W: -

1M: -

1Y: -

HPC Biosciences Quarterly Results

Pros & Cons

POSITIVES

Revenue growth increased by 10% YoY in the latest quarter, reflecting strong demand in the manufacturing sector.
Gross margins improved by 5% due to better operational efficiencies and cost management strategies.
Net profit margins expanded, indicating effective cost control and increased pricing power.

NEGATIVES

Operating expenses rose by 15% in the latest quarter, putting pressure on overall profitability.
Inventory turnover decreased, suggesting potential issues in supply chain management and excess stock.
Debt levels increased, raising concerns over financial leverage and future interest obligations.

Quarterly Results Data (Numbers are in Crore)

Field	Trend
Expenses	-
Operating Profit	-
Other Income	-
Tax	-